San Diego, CA · Founded 2002 · Privately Held (backing)
Developer of peptide therapeutics designed to assist in the treatment of autoimmune diseases and disorders. SelectION is based in San Diego, CA and was founded in 2002. Its last reported valuation was $195 million in Jun 2023. It has raised $19.6 million across 4 recorded rounds; the latest was a $5.4 million early-stage round in Sep 2025.
Last reported valuation
$195.0M
Oct 2026
Priced at
—
Total raised
$19.6M
Last round
Early Stage VC
Sep 2025
Team — not yet on record
No current team members for SelectION are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of SelectION with a free account
·Watch SelectION: the Monday email on marks, rounds and moves
